Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_1
2
50%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (50.0%)
N/A2 (50.0%)

Trials by Status

completed250%
unknown125%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_1

A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.

NCT06342349
terminatednot_applicable

Effect of Flow Rate and PH on Muscle Acidosis

NCT05165277
completedphase_1

A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine

NCT03369808
unknownnot_applicable

The Causal Connection Between Sng and Muscle Acidosis

NCT04049253

Clinical Trials (4)

Showing 4 of 4 trials
NCT06342349Phase 1

A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.

Completed
NCT05165277Not Applicable

Effect of Flow Rate and PH on Muscle Acidosis

Terminated
NCT03369808Phase 1

A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine

Completed
NCT04049253Not Applicable

The Causal Connection Between Sng and Muscle Acidosis

Unknown

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4